Ebola is a highly transmissible disease but its spread can be prevented through behavioural measures.
Articles on Ebola Virus Disease
Displaying all articles
Although treatments for Ebola have helped many people overcome this deadly disease, the virus can persist in the brain and cause a lethal relapse.
Emphasizing foreign origins of a disease can have racist connotations and implications for how people understand their own risk of disease.
While identifying a new disease by its place of origin seems intuitive, history shows that doing so can have serious consequences for the people that live there.
The current outbreak refuses to give in to efforts by an international team of health care workers, armed with vaccines and treatment that did not even exist during previous episodes.
Nearly everything known about Ebola virus persistence in the reproductive system has resulted from testing semen of West African Ebola virus disease survivors.
CC BY-NC-ND5.58 MB (download)
African researchers are on the front line of the fight to find a vaccine that will protect people against Ebola.
Research has identified a range of health complications in Ebola survivors. These include eye complications and vision problems.
The new Ebola vaccine is yet to be licensed but evidence shows that it protects against the strain of the virus.
Without the current experimental vaccine the Ebola outbreak in the DRC has the potential to spiral out of control.
Banning travel might not always be the best way to respond to a disease outbreak.
There have been ten Ebola outbreaks recorded from the DRC between 1976 and 2018 from different locations. This implies that the virus is widely spread.
History, and math, tell us that the Ebola virus spreads exponentially quickly. This means Ebola is a global problem and all nations need to rally – to stop the epidemic fast.
The DRC has developed good systems to diagnose Ebola. But it’s surveillance systems are still weak.
Lassa outbreaks are becoming more widespread in Nigeria but have not been given national emergency status like Ebola.
Top contributors
-
Principal Medical Scientist (PhD MPH), National Institute for Communicable Diseases
-
Postdoctoral Researcher, MRC-Centre for Virus Research, University of Glasgow
-
Professor in the faculty of Medicine, Mbarara University of Science and Technology
-
Assistant Professor of History, University of Pittsburgh
-
Fellow, Nigerian Academy of Science
-
Clinical Professor of Infectious Diseases and Associate Director, MRC-Centre for Virus Research, University of Glasgow
-
Associate professor, University of North Carolina at Chapel Hill
-
PhD Candidate, University of Manitoba
-
Reader in Theory of Probability, University of Sussex
-
Principal Investigator of Infectious Diseases, U.S. Army Medical Research Institute of Infectious Diseases
-
Assistant Professor/Canada Research Chair in emerging viruses, University of Manitoba
-
Professor of Ophthalmology, Emory University
-
PhD candidate, MRC Centre for virus research, University of Glasgow
-
Assistant Professor , Emory University
-
PhD Candidate, University of Manitoba